Literature DB >> 6751243

Zinc sulphate in rheumatoid arthritis.

P C Mattingly, A G Mowat.   

Abstract

To assess the antirheumatic activity of zinc sulphate, 27 patients with active rheumatoid arthritis took part in a 6-month, randomised, double-blind, between-group trial of oral zinc sulphate versus placebo. Twelve patients on zinc and 9 on placebo completed the trial, but no significant antirheumatic activity of zinc sulphate was demonstrated.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6751243      PMCID： PMC1001021          DOI： 10.1136/ard.41.5.456

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  6 in total

1.  Zinc sulfate in the treatment of rheumatoid arthritis.

Authors:  C Job; C J Menkes; F Delbarre
Journal:  Arthritis Rheum       Date:  1980-12

2.  Zinc: its relationship to osteoporosis in rheumatoid arthritis.

Authors:  A C Kennedy; G S Fell; P J Rooney; W H Stevens; W C Dick; W W Buchanan
Journal:  Scand J Rheumatol       Date:  1975       Impact factor: 3.641

3.  The effect of zinc on alkaline phosphatase activity in rheumatoid synovial tissue.

Authors:  J J Johnstone; L Bitensky; B Cashman; J Chayen
Journal:  Ann Rheum Dis       Date:  1978-12       Impact factor: 19.103

4.  Psoriatic arthritis treated with oral zinc sulphate.

Authors:  O J Clemmensen; J Siggaard-Andersen; A M Worm; D Stahl; F Frost; I Bloch
Journal:  Br J Dermatol       Date:  1980-10       Impact factor: 9.302

5.  Plasma zinc and its relationship to clinical symptoms and drug treatment in rheumatoid arthritis.

Authors:  Z Balogh; A F El-Ghobarey; G S Fell; D H Brown; J Dunlop; W C Dick
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

6.  Oral zinc sulphate in rheumatoid arthritis.

Authors:  P A Simkin
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321
  6 in total
  5 in total

1.  Effects of acute and chronic prednisolone treatment on serum zinc levels in rats with adjuvant arthritis.

Authors:  J Fontaine; J Nève; A Peretz; P Capel; J P Famaey
Journal:  Agents Actions       Date:  1991-07

2.  Reduced zinc in peripheral blood cells from patients with inflammatory connective tissue diseases.

Authors:  K L Svenson; R Hällgren; E Johansson; U Lindh
Journal:  Inflammation       Date:  1985-06       Impact factor: 4.092

3.  Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  James M Gwinnutt; Maud Wieczorek; Javier Rodríguez-Carrio; Andra Balanescu; Heike A Bischoff-Ferrari; Annelies Boonen; Giulio Cavalli; Savia de Souza; Annette de Thurah; Thomas E Dorner; Rikke Helene Moe; Polina Putrik; Lucía Silva-Fernández; Tanja Stamm; Karen Walker-Bone; Joep Welling; Mirjana Zlatković-Švenda; Francis Guillemin; Suzanne M M Verstappen
Journal:  RMD Open       Date:  2022-06

Review 4.  Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?

Authors:  Henry Yim Wu
Journal:  Clin Immunol       Date:  2008-10-19       Impact factor: 3.969

5.  A comparison of therapies which may influence trace metals in rheumatoid arthritis.

Authors:  J S Dixon; H A Bird; K E Surrall; N G Sitton; V Wright
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.